167 related articles for article (PubMed ID: 19381753)
1. FIC1-mediated stimulation of FXR activity is decreased with PFIC1 mutations in HepG2 cells.
Koh S; Takada T; Kukuu I; Suzuki H
J Gastroenterol; 2009; 44(6):592-600. PubMed ID: 19381753
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of progressive familial intrahepatic cholestasis type 1 and benign recurrent intrahepatic cholestasis type 1 mutations on canalicular localization of ATP8B1.
Folmer DE; van der Mark VA; Ho-Mok KS; Oude Elferink RP; Paulusma CC
Hepatology; 2009 Nov; 50(5):1597-605. PubMed ID: 19731236
[TBL] [Abstract][Full Text] [Related]
3. Bile salt excretory pump: biology and pathobiology.
Suchy FJ; Ananthanarayanan M
J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S10-6. PubMed ID: 16819395
[TBL] [Abstract][Full Text] [Related]
4. The membrane protein ATPase class I type 8B member 1 signals through protein kinase C zeta to activate the farnesoid X receptor.
Frankenberg T; Miloh T; Chen FY; Ananthanarayanan M; Sun AQ; Balasubramaniyan N; Arias I; Setchell KD; Suchy FJ; Shneider BL
Hepatology; 2008 Dec; 48(6):1896-905. PubMed ID: 18668687
[TBL] [Abstract][Full Text] [Related]
5. The lipid flippase heterodimer ATP8B1-CDC50A is essential for surface expression of the apical sodium-dependent bile acid transporter (SLC10A2/ASBT) in intestinal Caco-2 cells.
van der Mark VA; de Waart DR; Ho-Mok KS; Tabbers MM; Voogt HW; Oude Elferink RP; Knisely AS; Paulusma CC
Biochim Biophys Acta; 2014 Dec; 1842(12 Pt A):2378-86. PubMed ID: 25239307
[TBL] [Abstract][Full Text] [Related]
6. ATP8B1 deficiency disrupts the bile canalicular membrane bilayer structure in hepatocytes, but FXR expression and activity are maintained.
Cai SY; Gautam S; Nguyen T; Soroka CJ; Rahner C; Boyer JL
Gastroenterology; 2009 Mar; 136(3):1060-9. PubMed ID: 19027009
[TBL] [Abstract][Full Text] [Related]
7. Reduced hepatic expression of farnesoid X receptor in hereditary cholestasis associated to mutation in ATP8B1.
Alvarez L; Jara P; Sánchez-Sabaté E; Hierro L; Larrauri J; Díaz MC; Camarena C; De la Vega A; Frauca E; López-Collazo E; Lapunzina P
Hum Mol Genet; 2004 Oct; 13(20):2451-60. PubMed ID: 15317749
[TBL] [Abstract][Full Text] [Related]
8. FIC1 disease: a spectrum of intrahepatic cholestatic disorders.
van Mil SW; Klomp LW; Bull LN; Houwen RH
Semin Liver Dis; 2001 Nov; 21(4):535-44. PubMed ID: 11745041
[TBL] [Abstract][Full Text] [Related]
9. Phospholipase D2 mediates signaling by ATPase class I type 8B membrane 1.
Chen F; Ghosh A; Shneider BL
J Lipid Res; 2013 Feb; 54(2):379-85. PubMed ID: 23213138
[TBL] [Abstract][Full Text] [Related]
10. Folding defects in P-type ATP 8B1 associated with hereditary cholestasis are ameliorated by 4-phenylbutyrate.
van der Velden LM; Stapelbroek JM; Krieger E; van den Berghe PV; Berger R; Verhulst PM; Holthuis JC; Houwen RH; Klomp LW; van de Graaf SF
Hepatology; 2010 Jan; 51(1):286-96. PubMed ID: 19918981
[TBL] [Abstract][Full Text] [Related]
11. FIC1, the protein affected in two forms of hereditary cholestasis, is localized in the cholangiocyte and the canalicular membrane of the hepatocyte.
Eppens EF; van Mil SW; de Vree JM; Mok KS; Juijn JA; Oude Elferink RP; Berger R; Houwen RH; Klomp LW
J Hepatol; 2001 Oct; 35(4):436-43. PubMed ID: 11682026
[TBL] [Abstract][Full Text] [Related]
12. ATP8B1 and ABCB11 analysis in 62 children with normal gamma-glutamyl transferase progressive familial intrahepatic cholestasis (PFIC): phenotypic differences between PFIC1 and PFIC2 and natural history.
Davit-Spraul A; Fabre M; Branchereau S; Baussan C; Gonzales E; Stieger B; Bernard O; Jacquemin E
Hepatology; 2010 May; 51(5):1645-55. PubMed ID: 20232290
[TBL] [Abstract][Full Text] [Related]
13. Progressive familial intrahepatic cholestasis.
Srivastava A
J Clin Exp Hepatol; 2014 Mar; 4(1):25-36. PubMed ID: 25755532
[TBL] [Abstract][Full Text] [Related]
14. Intestinal bile salt absorption in Atp8b1 deficient mice.
Groen A; Kunne C; Paulusma CC; Kramer W; Agellon LB; Bull LN; Oude Elferink RP
J Hepatol; 2007 Jul; 47(1):114-22. PubMed ID: 17448567
[TBL] [Abstract][Full Text] [Related]
15. Progressive familial intrahepatic cholestasis, type 1, is associated with decreased farnesoid X receptor activity.
Chen F; Ananthanarayanan M; Emre S; Neimark E; Bull LN; Knisely AS; Strautnieks SS; Thompson RJ; Magid MS; Gordon R; Balasubramanian N; Suchy FJ; Shneider BL
Gastroenterology; 2004 Mar; 126(3):756-64. PubMed ID: 14988830
[TBL] [Abstract][Full Text] [Related]
16. [P4-ATP-ase Atp8b1/FIC1: structural properties and (patho)physiological functions].
Korneenko TV; Pestov NB; Okkelman IA; Modyanov NN; Shakhparonov MI
Bioorg Khim; 2015; 41(1):3-12. PubMed ID: 26050466
[TBL] [Abstract][Full Text] [Related]
17. Progressive familial intrahepatic cholestasis.
Jacquemin E
Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S26-35. PubMed ID: 23141890
[TBL] [Abstract][Full Text] [Related]
18. Sequencing of FIC1, BSEP and MDR3 in a large cohort of patients with cholestasis revealed a high number of different genetic variants.
Dröge C; Bonus M; Baumann U; Klindt C; Lainka E; Kathemann S; Brinkert F; Grabhorn E; Pfister ED; Wenning D; Fichtner A; Gotthardt DN; Weiss KH; McKiernan P; Puri RD; Verma IC; Kluge S; Gohlke H; Schmitt L; Kubitz R; Häussinger D; Keitel V
J Hepatol; 2017 Dec; 67(6):1253-1264. PubMed ID: 28733223
[TBL] [Abstract][Full Text] [Related]
19. Altered hepatobiliary gene expressions in PFIC1: ATP8B1 gene defect is associated with CFTR downregulation.
Demeilliers C; Jacquemin E; Barbu V; Mergey M; Paye F; Fouassier L; Chignard N; Housset C; Lomri NE
Hepatology; 2006 May; 43(5):1125-34. PubMed ID: 16628629
[TBL] [Abstract][Full Text] [Related]
20. Differences in presentation and progression between severe FIC1 and BSEP deficiencies.
Pawlikowska L; Strautnieks S; Jankowska I; Czubkowski P; Emerick K; Antoniou A; Wanty C; Fischler B; Jacquemin E; Wali S; Blanchard S; Nielsen IM; Bourke B; McQuaid S; Lacaille F; Byrne JA; van Eerde AM; Kolho KL; Klomp L; Houwen R; Bacchetti P; Lobritto S; Hupertz V; McClean P; Mieli-Vergani G; Shneider B; Nemeth A; Sokal E; Freimer NB; Knisely AS; Rosenthal P; Whitington PF; Pawlowska J; Thompson RJ; Bull LN
J Hepatol; 2010 Jul; 53(1):170-8. PubMed ID: 20447715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]